Análisis coste-efectividad de carbonato de lantano frente a clorhidrato de sevelámero en el tratamiento de la hiperfosfatemia en pacientes con enfermedad renal crónica en España-Reference-Cited by-同舟云学术

Análisis coste-efectividad de carbonato de lantano frente a clorhidrato de sevelámero en el tratamiento de la hiperfosfatemia en pacientes con enfermedad renal crónica en España

Published:2014-04-25 Issue:1 Volume:12 Page:11-22
ISSN:1695-405X
Container-title:PharmacoEconomics Spanish Research Articles
language:es
Short-container-title:PharmacoEcon Span Res Artic

Author:

González-Parra Emilio,Gros Blanca,Galán Antonio,Herrero José Antonio,Oyagüez Itziar,Keith Michael,Casado Miguel Ángel

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s40277-014-0031-1.pdf

Reference51 articles.

1. Junyent M, Martínez M, Borràs M, et al. Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study. BMC Nephrol. 2010;11:14.

2. Vegter S, Tolley K, Keith MS, et al. Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients: a Canadian payer perspective. Clin Ther. 2012;34(7):1531–43.

3. Torregrosa JV, Bover J, Cannata Andía J, et al. Guías S.E.N. Nefrologia. 2011;31(Suppl 1):3–32.

4. Qunibi WY. Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD). Kidney Int Suppl. 2004;90:S8–S12.

5. Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607–17.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations;The European Journal of Health Economics;2021-03-06